| Literature DB >> 1691267 |
A J Hamilton1, M A Bartholomew, L E Fenelon, J Figueroa, R J Hay.
Abstract
A monoclonal antibody (mAb) exhibiting a high degree of species specificity for the yeast phase of the dimorphic fungus Histoplasma capsulatum was produced by a modification of the standard mAb production protocol. The technique for generating mAbs involved the use of the immunosuppressive drug cyclophosphamide to diminish the response in mice to immunodominant cross-reactive epitopes. This mAb exhibited clear specificity and did not react by ELISA with the closely related genera Blastomyces, Paracoccidioides and Sporothrix. In Western blots it recognized a linear determinant on a 70-75 kDa molecule in H. capsulatum antigen, with an extremely faint reactivity to antigens of identical molecular mass derived from Sporothrix and Paracoccidioides, and no reactivity against Blastomyces antigen.Entities:
Mesh:
Substances:
Year: 1990 PMID: 1691267 DOI: 10.1099/00221287-136-2-331
Source DB: PubMed Journal: J Gen Microbiol ISSN: 0022-1287